Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nicotinamide adenine dinucleotide (NAD) and its related enzymes are central to cellular metabolism, energy production, and signaling in all living cells. NAD exists in two forms: the oxidized form (NAD⁺) and the reduced form (NADH). These molecules act as essential cofactors for a wide range of enzymes, particularly those involved in redox reactions. NAD-related enzymes primarily function as oxidoreductases—catalyzing electron transfer during metabolic processes such as glycolysis, the citric acid cycle (Krebs cycle), and oxidative phosphorylation. Several enzyme families use NAD⁺ as a substrate, including Sirtuins (protein deacetylases), PARPs (Poly(ADP-ribose) polymerases), and CD38/CD157/SARM1 (glycohydrolases). Declining levels of cellular/nuclear/mitchondrial pools of these cofactors are linked with aging processes and age-related diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nicotinamide Adenine Dinucleotide-Related Enzymes (None).